President and CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Patient PortalAdult ClinicPediatricsEye CareMake an AppointmentBillingInfo for Healthcare Professionals
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Sethu Reddy, M.D., M.B.A., F.R.C.P.C., F.A.C.P., M.A.C.E. | Chief, Adult Diabetes

Position

Chief, Adult Diabetes

Special
Interests

General Diabetes, Insulin Resistance, Brittle Diabetes, Type 2 Diabetes And Pumps, Lipodystrophy, Obesity, Post-Transplant Diabetes, Post-Pancreatectomy Diabetes, In-Patient Diabetes

Medical School

Memorial University of Newfoundland, 1980

Internship

Memorial University of Newfoundalnd, Canada

Residency

University of Toronto (1982-83)

Fellowship

Endocrinology, Diabetes & Metabolism at University of Toronto (1983-85)

Specialty Training

Research Fellowship in Molecular & Cellular Physiology, Joslin Diabetes Center, Boston, 1985-88

Certification

Internal Medicine and Endocrinology, Diabetes & Metabolism

Languages

English, Telugu

In 2007, Dr. Reddy received the distinction of Mastership in the American College of Endocrinology.

He is past-Chairman of Endocrinology, Diabetes & Metabolism at Cleveland Clinic, and most recently was VP for US Medical Affairs at Merck. 

He was a key sponsor of Merck's adherence initiative and was the Lead for Medical Solutions as part of the Global Customer Centricity initiative at Merck. He has consistently supported continuing education and collaboration between academia and pharma.

Dr. Reddy has been actively involved in numerous clinically relevant projects with AACE since 1996 and is currently on the Board of Trustees for the American College of Endocrinology.